These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20926476)

  • 1. Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
    Grottke O; Braunschweig T; Zimmermann L; Kopp R; Lauritzen B; Coburn M; Tolba R; Rossaint R
    Br J Anaesth; 2010 Dec; 105(6):789-97. PubMed ID: 20926476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
    Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
    PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
    Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
    J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
    Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
    J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin patch in a pig model with blunt liver injury under severe hypothermia.
    Zentai C; Braunschweig T; Rossaint R; Daniels M; Czaplik M; Tolba R; Grottke O
    J Surg Res; 2014 Apr; 187(2):616-24. PubMed ID: 24332553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of TachoSil in a coagulopathic pig model with blunt liver injuries.
    Grottke O; Braunschweig T; Daheim N; Coburn M; Grieb G; Rossaint R; Tolba R
    J Surg Res; 2011 Nov; 171(1):234-9. PubMed ID: 20452609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury.
    Grottke O; Braunschweig T; Henzler D; Coburn M; Tolba R; Rossaint R
    Crit Care; 2010; 14(2):R62. PubMed ID: 20398253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant FVIIa in hypothermic, coagulopathic pigs with liver injuries.
    Klemcke HG; Delgado A; Holcomb JB; Ryan KL; Burke A; DeGuzman R; Scherer M; Cortez D; Uscilowicz J; Macaitis JM; Bliss J; Wojtaszczyk J; Christensen S; Currier H; Pusateri AE
    J Trauma; 2005 Jul; 59(1):155-61; discussion 161. PubMed ID: 16096556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
    Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
    Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances.
    Gkiougki E; Mitsiakos G; Chatziioannidis E; Papadakis E; Nikolaidis N
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):221-6. PubMed ID: 23511491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
    Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
    J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries.
    Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Aoki N; Meng ZH; Tweardy DJ; Hoots K
    J Am Coll Surg; 2003 May; 196(5):691-7. PubMed ID: 12742197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy--a porcine model.
    Fries D; Haas T; Klingler A; Streif W; Klima G; Martini J; Wagner-Berger H; Innerhofer P
    Br J Anaesth; 2006 Oct; 97(4):460-7. PubMed ID: 16885172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model.
    Fries D; Krismer A; Klingler A; Streif W; Klima G; Wenzel V; Haas T; Innerhofer P
    Br J Anaesth; 2005 Aug; 95(2):172-7. PubMed ID: 15923269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
    Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
    Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.